Insider John R. Jeffrey Jr. lists sales and option exercise (AGX)

Rhea-AI Filing Summary

Argan, Inc. submitted a Form 144 notice related to proposed sales of Common Stock by an insider. The filing lists an option exercise/equity grant for 3,636 shares on 01/16/2026 and shows prior sales of 5,000 shares on 01/27/2026 and 4,556 shares on 03/31/2026 (proceeds $2,459,556.60 for the 03/31/2026 sale). The notice names John R. Jeffrey, Jr. as the selling person and lists broker information for Charles Schwab & Co.

Insights

Securities Lawyer

Form 144 records proposed resale and recent dispositions by an insider.

The notice lists an option exercise/equity grant of 3,636 shares dated 01/16/2026 and two prior dispositions: 5,000 shares on 01/27/2026 and 4,556 shares on 03/31/2026, with proceeds of $2,459,556.60 shown for the latter. The filing names the selling person as John R. Jeffrey, Jr. and identifies Charles Schwab & Co. as the broker.

Form 144 is a procedural notice required when affiliates plan to sell restricted or control securities in reliance on the resale rules; timing and settlement depend on market arrangements and any applicable transfer restrictions. The filing itself does not state which sale methods will be used or whether the company receives proceeds.

Key Figures

Option exercise / equity grant: 3,636 shares Sale on 01/27/2026: 5,000 shares Sale on 03/31/2026: 4,556 shares +1 more

4 metrics

Option exercise / equity grant 3,636 shares option exercise dated <date>01/16/2026</date>

Sale on 01/27/2026 5,000 shares disposition reported in past 3 months

Sale on 03/31/2026 4,556 shares disposition reported in past 3 months

Proceeds for 03/31/2026 sale $2,459,556.60 proceeds listed for the 03/31/2026 disposition

Key Terms

Form 144, OPTION EXERCISE, equity grant

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

OPTION EXERCISE financial

"01/16/2026 | OPTION EXERCISE"

equity grant financial

"01/16/2026 | EQUITY GRANT"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Charles Schwab & Co. Inc. 3000 Schwab Way Westlake TX 76262	3636	2236140	13945962	04/21/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/16/2026	EQUITY GRANT	Issuer			3636	01/16/2026	OPTION EXERCISE

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
John R. Jeffrey, Jr. c/o Argan, Inc. 4075 Wilson Blvd, Suite 440 Arlington VA 22203	Common Stock	01/27/2026	5000	1803900
John R. Jeffrey, Jr. c/o Argan, Inc. 4075 Wilson Blvd, Suite 440 Arlington VA 22203	Common Stock	03/31/2026	4556	2459556.60

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Argan, Inc.'s Form 144 for AGX show?

The Form 144 lists proposed resale-related activity by an affiliate. It records an option exercise/equity grant for 3,636 shares on 01/16/2026 and prior dispositions on 01/27/2026 and 03/31/2026.

Who is the selling person named in the AGX Form 144?

The filing names John R. Jeffrey, Jr. as the selling person. The notice provides his address tied to Argan, Inc. as the reported source of the shares to be sold.

How many shares were sold in the past three months per the AGX filing?

The Form 144 shows two past dispositions totaling 9,556 shares: 5,000 shares on 01/27/2026 and 4,556 shares on 03/31/2026, with proceeds listed for the latter sale.

Does the AGX filing show proceeds from recent sales?

Yes. The entry for the 03/31/2026 disposition records proceeds of $2,459,556.60. Other sale entries do not show proceeds in the provided excerpt.

Was there an option exercise disclosed in the AGX Form 144?

The notice records an OPTION EXERCISE / EQUITY GRANT dated 01/16/2026 for 3,636 shares, indicating securities issued or acquired by exercise on that date as shown in the filing.